$0.021
-0.010 (-46.75%)收盤時
OCEA 同業比較
In the context of the broader market, OCEA competes directly with industry leaders such as INDP and SNGX. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, OCEA's gross margin of N/A stands against INDP's N/A and SNGX's N/A. Such benchmarking helps identify whether Ocean Biomedical Inc is trading at a premium or discount relative to its financial performance.
Financials
FY2022Q1
0.00
Total Revenue
FY2024Q4
YoY:
-365.61%
-1.75M
Operating Profit
FY2024Q4
YoY:
-101.68%
283.00K
Net Income after Tax
FY2024Q4
YoY:
-101.61%
0.01
EPS - Diluted
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。